CSF3 and acute graft versus host disease: In addition, treatment of peripheral blood cells with G-SCF can increase the production of γδ-Treg cells in vivo and in vitro, and support acute graft-versus-host disease in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation (28).